SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001341004-16-001356
Filing Date
2016-04-27
Accepted
2016-04-27 17:23:10
Documents
5
Period of Report
2016-04-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm 8-K 54981
2 EXHIBIT 10.1 - EMPLOYMENT AGREEMENT ex-agmt.htm EX-10.1 372216
3 EXHIBIT 99.1 - PRESS RELEASE ex-pr.htm EX-99.1 17915
4 logo.jpg GRAPHIC 9247
5 sm-logo.jpg GRAPHIC 3479
  Complete submission text file 0001341004-16-001356.txt   464313
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 161596394
SIC: 2834 Pharmaceutical Preparations